Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Seminars in Cancer Biology|January 1, 2020
Somatic copy number aberrations in metastatic patients: The promise of liquid biopsiesShawn Baldacchino, Godfrey GrechMethods (San Diego, Calif.)|October 24, 2018
Bead-based RNA multiplex panels for biomarker detection in oncology samplesJeanesse Scerri, Shawn Baldacchino, Christian Saliba, et al.Journal of Visualized Experiments : Jove|August 21, 2018
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival MaterialShawn Baldacchino, Christian Saliba, Jeanesse Scerri, et al.The American Journal of Dermatopathology|March 15, 2023
Neuroendocrine Transdifferentiation in Cutaneous Melanoma: A Case Report and Review of the LiteratureDavid Pisani, Daniel Micallef, Jeanesse Scerri, et al.The EPMA Journal|January 28, 2014
Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720Shawn Baldacchino, Christian Saliba, Vanessa Petroni, et al.International Journal of Hematology|December 3, 2013
Expression of different functional isoforms in haematopoiesisGodfrey Grech, Joel Pollacco, Mark Portelli, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2016
Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic optionsGodfrey Grech, Shawn Baldacchino, Christian Saliba, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 17, 2017
CIP2A expression predicts recurrences of tamoxifen-treated breast cancerShawn Baldacchino, Laura M Wastall, Christian Saliba, et al.Journal of Cellular Physiology|March 27, 2019
Loss of MCL1 function sensitizes the MDA-MB-231 breast cancer cells to rh-TRAIL by increasing DR4 levelsAnna De Blasio, Giovanni Pratelli, Rosa Drago-Ferrante, et al.Journal of Cellular Physiology|July 18, 2019
A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cellsAnna De Blasio, Riccardo Di Fiore, Giovanni Pratelli, et al.Pageof 2